Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
批准号:
10312023
负责人:
Nora Amanda Barrett
金额:
$59.61万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31
关键词:
Activities of Daily LivingAddressAffinityAllergensAlternariaAspirinAsthmaBasal CellBasophilsBiologicalBiological AssayBrush CellCell Culture TechniquesCell Differentiation processCell physiologyCellsCollaborationsCutaneousDataData SetDatabasesDevelopmentDiseaseEdemaEffector CellEosinophiliaEpithelialEpithelial CellsGene Expression ProfileGenerationsGenetic TranscriptionGoblet CellsHumanImmunityIn VitroInflammationInflammation MediatorsInflammatoryInhalationInterleukin-13IntestinesKnock-outLeadLeukotriene C4Leukotriene D4Leukotriene E4Liquid substanceLoxP-flanked alleleLungLymphoid CellMediatingMediator of activation proteinMetaplastic CellMoldsMucinsMucositisMucous body substanceMusNasal PolypsNosePathway interactionsPatientsPopulationProcessProductionProteinsPyroglyphidaeRegulationReporterResistanceRespiratory MucosaRespiratory SystemRoleSTAT6 geneSamplingSeveritiesSignal TransductionSourceStructure of mucous membrane of noseSystemTSLP geneTherapeuticairborne allergenairway epitheliumairway inflammationairway obstructionairway remodelingaspirin-exacerbated respiratory diseaseautocrinebronchial epitheliumcell typecysteinyl-leukotrieneeosinophilgut microbiotaimprintinhibitorinterestmucosal sitenovelpatient tolerabilitypolyposisprogramsreceptorrecruitrespiratoryrespiratory virusresponsesingle-cell RNA sequencingstem cellstherapeutic targettranscriptome sequencing
中文摘要
项目摘要
LTE4是一种稳定的半胱氨基白三烯(CysLT),在哮喘患者的生物液中检测到
由过敏原挑战、阿司匹林和呼吸道病毒引发。LTE4可引起正常人皮肤浮肿
控制和诱导哮喘患者的嗜碱性粒细胞和嗜酸性粒细胞向肺内募集。我们的小组最近
发现CysLT3R(也称为Oxgr1或GPR99)是LTE4的高亲和力受体,并证明了它
介导LTE4诱导的缺乏常规CysLT受体、CysLT1R和
CysLT2R。然而,LTE4诱导肺部病理生物学的机制(S)仍然知之甚少
CysLT3R的作用尚未阐明。我们发现CysLT3R在这两种小鼠身上都有表达
和人类呼吸道上皮细胞(EPC),并控制其激活和发育。作为CysLT3R
对目前可用的cysLT受体抑制剂具有耐药性,这项提案的发现将确定
CysLT3R是否是减少粘液产生、气流阻塞或2型的合理治疗靶点
哮喘中的炎症。
利用单细胞RNA-Seq和我们开发的一种新的CysLT3R菌落菌株,除了
几个谱系报告和无效菌株,Aim 1将定义CysLT3R
调节小鼠肺内皮祖细胞的激活和发育。在目标2中,我们将描述候选效应器
CysLT3R中的路径-我们在RNA-seq数据集中定义的扩展的呼吸道内皮祖细胞。这一目标提出了
为了扩展我们关于纯化的稀有EPC子集的RNA-seq数据,并使用细胞特异性基因敲除来表征
EPC效应蛋白。在目标3中,我们将利用不断增长的单细胞rna-seq数据库。
我们是从鼻息肉患者发展而来的。我们将利用我们在转录方面的巨大差异
查看不同的疾病状态(阿司匹林加重的呼吸系统疾病,阿司匹林耐受患者
鼻息肉和对照样本),以寻找独特的EPC效应器程序,并定义哪些可能是
受CysLT3R调控。最后,我们将使用一个体外系统来培养正常人的支气管上皮细胞。
确定CysLT3R调节人呼吸道内皮祖细胞分化的程度,并验证
发生这种情况的途径。
英文摘要
Project Summary
LTE4 is the stable cysteinyl leukotriene (cysLT), detected in the biologic fluids of patients with asthma
triggered by allergen challenge, aspirin, and respiratory viruses. LTE4 elicits cutaneous edema in normal
controls and elicits basophil and eosinophil recruitment to the lung in patients with asthma. Our group recently
identified CysLT3R (also called Oxgr1 or GPR99) as the high affinity receptor for LTE4 and demonstrated that it
mediates LTE4-elicited cutaneous edema in mice lacking the conventional cysLT receptors, CysLT1R and
CysLT2R. However, the mechanism(s) by which LTE4 induces lung pathobiology remains poorly understood
and the role of CysLT3R has not been elucidated. We have found that CysLT3R is expressed on both murine
and human respiratory epithelial cells (EpCs) and controls both their activation and development. As CysLT3R
is resistant to currently available cysLT receptor inhibitors, the findings from this proposal will determine
whether CysLT3R is a logical therapeutic target to reduce mucus production, airflow obstruction, or type 2
inflammation in asthma.
Using single cell RNA-Seq and a novel CysLT3R floxed strain that we have developed, in addition to
several lineage reporter and null strains, Aim 1 will define the cellular mechanisms by which CysLT3R
regulates murine lung EpC activation and development. In Aim 2, we will characterize candidate effector
pathways in CysLT3R-expanded airway EpCs that we have defined in an RNA-seq dataset. This aim proposes
to expand our RNA-seq data on a purified rare EpC subset, and use a cell-specific knockout to characterize an
EpC effector protein of interest. In Aim 3 we will take advantage of a growing single cell RNA-seq data base
we are developing from patients with nasal polyps. We will exploit the tremendous transcriptional distinction we
see across different disease states (aspirin-exacerbated respiratory disease, aspirin-tolerant patients with
nasal polyposis, and control samples) to look for unique EpC effector programs and define those which may be
regulated by CysLT3R. Finally, we will use an in vitro system in normal human bronchial epithelial cell culture
to determine the extent to which CysLT3R regulates human airway EpC differentiation and validate the
pathways through which this occurs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
-
批准号:10541112
-
项目类别:
-
资助金额:$59.61万
-
财政年份:2019
-
负责人:Nora Amanda Barrett
-
依托单位:
Type 2 Immunity Elicited Through an LTE4/GPR99-Dependent Pathway
-
批准号:10083699
-
项目类别:
-
资助金额:$59.61万
-
财政年份:2019
-
负责人:Nora Amanda Barrett
-
依托单位:
Allergic Pulmonary Inflammation Through the Dectin-2 Pathway
-
批准号:8786600
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2014
-
负责人:Nora Amanda Barrett
-
依托单位:
Allergic Pulmonary Inflammation Through the Dectin-2 Pathway
-
批准号:8612049
-
项目类别:
-
资助金额:$40.55万
-
财政年份:2014
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
-
批准号:10456245
-
项目类别:
-
资助金额:$37.57万
-
财政年份:2011
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
-
批准号:10626852
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2011
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2. Basal Cell Dysplasia in Type 2 Immunopathology
-
批准号:10260784
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2011
-
负责人:Nora Amanda Barrett
-
依托单位:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
-
批准号:8304953
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Nora Amanda Barrett
-
依托单位:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
-
批准号:7932080
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Nora Amanda Barrett
-
依托单位:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
-
批准号:8507466
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Nora Amanda Barrett
-
依托单位:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
-
批准号:8115952
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Nora Amanda Barrett
-
依托单位:
Innate Signaling, Cysteinyl Leukotrienes, and Asthma Elicited by House Dust Mite
-
批准号:7572197
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2: CysLT2R Regulation of Type 2 Immunity
-
批准号:9973141
-
项目类别:
-
资助金额:$84.14万
-
财政年份:--
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2: CysLT2R Regulation of Type 2 Immunity
-
批准号:9156879
-
项目类别:
-
资助金额:$40.27万
-
财政年份:--
-
负责人:Nora Amanda Barrett
-
依托单位:
Project 2: CysLT2R Regulation of Type 2 Immunity
-
批准号:9294922
-
项目类别:
-
资助金额:$35.92万
-
财政年份:--
-
负责人:Nora Amanda Barrett
-
依托单位:
海外基金